Condition
Sezary Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Sezary Syndrome clinical trials that are recruiting, at sites in 3 countries (most in United States (7), Sweden (1), South Korea (1)). By phase: Phase 2 (2), Phase 1/2 (1). The most active sponsors are University of Pittsburgh (2), City of Hope Medical Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 3Countries
Newest Sezary Syndrome clinical trials
All recruiting trials (9)
-
Poteligeo (mogamulizumab) for adults with mycosis fungoides or Sézary syndrome
This project will try Poteligeo (mogamulizumab) in adults with mycosis fungoides or Sézary syndrome who have had at least one prior systemic therapy to see how safe and effective it is in routine care in Korea.
-
Registry for individuals with T-cell lymphoma
This study is gathering information from people with T-cell lymphoma to help researchers learn more about the disease and improve treatments.
-
Using extracorporeal photopheresis to treat Sezary Syndrome
This study is testing if a treatment called extracorporeal photopheresis can help people with Sezary Syndrome improve their skin condition and overall health.
-
Treatment for erythrodermic cutaneous T cell lymphoma using photopheresis and mogamulizumab
This study is testing a new treatment combining light therapy and a medication for people with a rare skin cancer called erythrodermic cutaneous T cell lymphoma to see if it helps them feel better and improves their quality of life.
-
Identifying biomarkers in patients with skin lymphomas.
This study is trying to find specific markers in the blood and skin of people with skin lymphomas to see if they can help improve treatment options for patients with Mycosis Fungoides and Sézary Syndrome.
-
Combining mogamulizumab with low-dose total skin electron beam therapy for treating skin lymphomas
This study is testing if combining a new drug called mogamulizumab with a special type of skin radiation therapy can help people with certain skin lymphomas feel better.
-
Durvalumab With or Without Lenalidomide for Relapsed/Refractory Cutaneous or Peripheral T-Cell Lymphoma
This study tests whether adding lenalidomide to durvalumab is safe and helps treating relapsed or refractory cutaneous or peripheral T-cell lymphoma.
-
Collection of tissue samples from patients with Cutaneous T-cell lymphoma
This study is collecting tissue samples from patients with Cutaneous T-cell lymphoma and related conditions to help researchers learn more about the disease and find better treatments.
-
Collection of blood, urine, and tissue samples for research on skin conditions
This study is collecting blood, urine, and tissue samples from people with skin conditions like cutaneous T-cell lymphoma, eczema, and atopic dermatitis to help improve treatments in the future.
Related topics
Quick answers
How many Sezary Syndrome clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (7 trials), Sweden (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.